Deals, Partnering

Gilead inks pact on experimental RSV treatment

Posted on 20 April 2011

Tags: , ,

Gilead Sciences and MicroDose Therapeutx have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637. See the deal terms and full press release on the Gilead/MicroDose agreement

Print Friendly, PDF & Email

Leave a Reply

 

cpbannerad300x150new1gif
rauconbadgejpg
e80banner300x150animgif
cpbannerad300x150new2gif
rauconbadgejpg
a1banner300x150animgif